Each 0.5 tsp serving contains: Euphorbia pilulifera 4:1 extract (DHE: 18.6 mg) 4.65 mg • Guarea rusbyi 4:1 extract (DHE: 6.8 mg) 1.6 mg • Lactuca Serriola 1.7 mg • Polygala senega 4:1 extract (DHE: 2.8 mg) 0.7 mg • Scilla 2:1 extract (DHE: 2.8 mg) 1.4 mg. Other Ingredients: Caramel, Anhydrous Citric Acid, Cocillana Composee, Ethanol, Glycerin, Menthol, Methylparaben, Peach Flavour, Propylparaben, Sucrose, Purified Water. Scilla 2:1 extract (DHE: 2.8 mg) 1.4 mg. Other Ingredients: Caramel, Anhydrous Citric Acid, Cocillana Composee, Ethanol, Glycerin, Menthol, Methylparaben, Peach Flavour, Propylparaben, Sucrose, Purified Water.
Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
In 2004, Canada began regulating natural medicines as a category of products separate from foods or drugs. These products are officially recognized as "Natural Health Products." These products include vitamins, minerals, herbal preparations, homeopathic products, probiotics, fatty acids, amino acids, and other naturally derived supplements.
In order to be marketed in Canada, natural health products must be licensed. In order to be licensed in Canada, manufacturers must submit applications to Health Canada including information about uses, formulation, dosing, safety, and efficacy.
Products can be licensed based on several criteria. Some products are licensed based on historical or traditional uses. For example, if an herbal product has a history of traditional use, then that product may be acceptable for licensure. In this case, no reliable scientific evidence is required for approval.
For products with non-traditional uses, some level of scientific evidence may be required to support claimed uses. However, a high level of evidence is not necessarily required. Acceptable sources of evidence include at least one well-designed, randomized, controlled trial; well-designed, non-randomized trials; cohort and case control studies; or expert opinion reports.
Finished products licensed by Health Canada must be manufactured according to Good Manufacturing Practices (GMPs) as outlined by Health Canada.
Below is general information about the effectiveness of the known ingredients contained in the product Sirop Cocillana Compose. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient reliable information available about the effectiveness of cocillana.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Sirop Cocillana Compose. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient reliable information available about the safety of cocillana.
PREGNANCY: POSSIBLY UNSAFE
when used orally due to its purported ability to induce menstruation (18).
LACTATION:
Insufficient reliable information available; avoid using.
POSSIBLY SAFE ...when used orally and appropriately, short-term (12). Senega extract has been used with apparent safety in clinical research at doses of 300 mg daily for 4-8 weeks (96991,96992).
POSSIBLY UNSAFE ...when used orally, long-term. Prolonged use can cause gastrointestinal irritation (12). There is insufficient reliable information available about the safety of senega when used topically.
PREGNANCY: LIKELY UNSAFE
when used orally; senega appears to have uterine and menstrual flow stimulant effects (12,19).
There is insufficient reliable information available about the safety of the topical use of senega during pregnancy.
LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product Sirop Cocillana Compose. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Below is general information about the adverse effects of the known ingredients contained in the product Sirop Cocillana Compose. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...None reported; however, a thorough evaluation of safety outcomes has not been conducted.
General ...Orally, senega seems to be well tolerated. The most common adverse effects are gastrointestinal irritation, dyspepsia, diarrhea, queasiness, vomiting, and dizziness. These adverse effects are usually associated with large doses or prolonged use (2,4,8,18,96992).
Gastrointestinal ...Orally, senega can cause mild dyspepsia (96992). Prolonged use of senega can cause gastrointestinal irritation (2). Large doses of senega can cause diarrhea (8), queasiness (18), and vomiting (4).
Immunologic ...There is a case of IgE-mediated occupational asthma and rhinitis due to inhalation of senega powder (96987).
Neurologic/CNS ...Orally, large amounts of senega can cause dizziness (8).
